Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation

British Journal of Pharmacology

Volumn 117, Issue 8, 1996, Pages 1773-1779

  Payá, Miguel ^a   Terencio, M Carmen ^a   Ferrándiz, M Luisa ^a   Alcaraz, M José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Manoalide; Myeloperoxidase; Phospholipase A2; Rat air pouch; Scalaradial; Zymosan

Indexed keywords

COLCHICINE; LEUKOTRIENE B4; MANOALIDE; MYELOPEROXIDASE; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; SCALARADIAL; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EXUDATE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029985501     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15353.x     Document Type: Article

References (48)

1. ANGEL, J., COLARD, O., CHEVY, F. & FOURNIER, C. (1993). Interleukin-1-mediated phospholipid breakdown and arachidonic acid release in human synovial cells. Arthritis Rheum., 36, 158-167.
2. 2 enzymes. Proc. Natl. Acad. Sci. U.S.A., 91, 11060-11064.
3. 2 activity in resting and activated human neutrophils. Substrate specificity, pH dependence, and subcellular localization. J. Biol. Chem., 263, 1929-1936.
4. 2, on human neutrophil function. Biochem. Pharmacol., 47, 1661-1668.
5. 2 and arthritis. Arthritis Rheum., 36, 190-198.
6. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. 2+ -dependent translocation domain with homology by PKC and GAP. Cell, 65, 1043-1051.
8. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A., 87, 7708-7712.
9. 2 activation in human neutrophils. Immunology, 75, 157-163.
10. DAWSON, J., SEDGWICK, A.D., EDWARDS, J.C. & LEES, P. (1991). A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int. J. Tissue React., 13, 171-185.
11. 2 by scalaradial. Biochem. Pharmacol., 42, 1621-1626.
12. DE YOUNG, L.M., KHEIFETS, J.B., BALLARON, S.J. & YOUNG, J.M. (1989). Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions, 26, 335-341.
13. EDWARDS, J.C.W., SEDGWICK, A.D. & WILLOUGHBY, D.A. (1981). The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol., 134, 147-156.
14. EMILSSON, A. & SUNDLER, R. (1984). Differential activation of phosphatidylinositol deacylation and a pathway via diphosphoinositide in macrophages responding to zymosan and ionophore A23187. J. Biol. Chem., 259, 3111-3116.
15. 4 and platelet-activating factor biosynthesis in human neutrophils. J. Pharmacol. Exp. Ther., 271, 1418-1426.
16. FERRANDIZ, M.L. & FOSTER, S.J. (1991). Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions, 32, 289-294.
17. FERRANDIZ, M.L., SANZ, M.J., BUSTOS, G., PAYA, M., ALCARAZ, M.J. & DE ROSA, S. (1994). Avarol and avarone, two new anti-inflammatory agents of marine origin. Eur. J. Pharmacol., 253, 75-82.
18. 2 associated with rabbit polymorphonuclear leukocyte granules. J. Lipid Res., 15, 380-388.
19. 2 and inflammatory responses in mice. Life Sci., 54, 333-338.
20. 2 enzymes: regulation and inhibition. Trends Pharmacol. Sci., 14, 92-98.
21. 2 by the marine natural product, manoalide. Biochem. Pharmacol., 39, 1557-1564.
22. JOSE, P.J. (1987). Complement-derived peptide mediators of inflammation. Br. Med. Bull., 43, 336-349.
23. 2. J. Biol. Chem. 264, 5768-5775.
24. 2. Biochim. Biophys. Acta., 117, 217-231.
25. 2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation. J. Pharmacol. Exp. Ther., 268, 709-717.
26. 2 activity in membrane preparation of rabbit neutrophils. Absence of activation by fMet-Leu-Phe, phorbol 12-myristate 13-acetate and A-kinase. Biochem. J., 250, 343-348.
27. MAYER, A.M.S., GLASER, K.B. & JACOBS, R.S. (1988). Regulation of eicosanoid biosynthesis in vitro and in vivo by the marine natural product manoalide: a protein inactivator of venom phospholipases. J. Pharmacol. Exp. Ther., 244, 871-878.
28. MEACHER, L.C., MOONGA, B.S., HASLETT, C., HUANG, C.L.-H. & ZAIDI, M. (1991). Single pulses of cytoplasmic calcium associated with phagocytosis of individual zymosan particles by macrophages. Biochem. Biophys. Res. Commun., 177, 460-465.
29. 2. Br. J. Pharmacol., 110, 447-453.
30. MORONEY, M.A., ALCARAZ, M.J., FORDER, R.A., CAREY, F. & HOULT, J.R.S. (1988). Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J. Pharm. Pharmacol., 40, 787-792.
31. 2 enzymes: regulation and physiological role. Biochem. Pharmacol., 48, 1-10.
32. 2 and phospholipase C. Eur. J. Pharmacol., 243, 213-219.
33. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J. Clin. Invest., 92, 2516-2523.
34. 2 inhibitors from marine organisms. J. Nat. Prod., 55, 1701-1717.
35. 2 in human neutrophil cytosol. Biochim. Biophys. Acta., 1168, 37-44.
36. 2. Biochim. Biophys. Acta., 1167, 272-280.
37. SCHORLEMMER, H.U., EDWARDS, J.H., DAVIES, P. & ALLISON, A.C. (1977). Macrophage responses to mouldy hay dust, Micropholyspora faeni and zymosan, activators of complement by the alternative pathway. Clin. Exp. Immunol. 27, 198-203.
38. SUZUKI, K., OTA, H., SASAGAWA, S., SAKARANI, T. & FUJIKURA, T. (1983). Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem., 132, 345-352.
39. 2 which preferentially hydrolyzes an arachidonoyl residue. FEBS Lett., 282, 326-330.
40. 2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity. J. Pharmacol. Exp. Ther., 271, 852-859.
41. 2 activity of lysosomal origin secreted by polymorphonuclear leucocytes during phagocytosis or on treatment with calcium. Biochim. Biophys. Acta., 665, 571-577.
42. 1 macrophage-like cell line. J. Biol. Chem., 263, 3079-3085.
43. 2 in the pathobiology of disease. Lab. Invest., 55, 391-404.
44. 2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation, 12, 549-561.
45. WEDMORE, C.V. & WILLIAMS, T.J. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature, 289, 646-650.
46. 2 in concert with polymorphonuclear leukocytes. J. Biol. Chem., 269, 26331-26337.
47. 2 by resident mouse peritoneal macrophages. Biochem. J., 200, 441-444.
48. 2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J. Biol. Chem., 265, 6675-6681.